Oliver J. Stoetzer

Treatment of advanced gastrointestinal cancer with genetically modified autologous mesenchymal stem cells: Results from the phase 1/2 TREAT‐ME‐1 trial

Jobst C. von Einem, Christine Guenther, Hans‐Dieter Volk et al. · International Journal of Cancer · 2019 · 117 citations · Full text

Medicine, Immunology, Oncology +17

Association of bcl-2, bax, bcl-xL and interleukin-1 beta-converting enzyme expression with initial response to chemotherapy in acute myeloid leukemia.

Oliver J. Stoetzer, M. Darsow, E. Gullis et al. · PubMed · 1996 · 86 citations

Medicine, Cancer Biology, Oncology +13

Circulating immunogenic cell death biomarkers HMGB1 and RAGE in breast cancer patients during neoadjuvant chemotherapy

Oliver J. Stoetzer, Debora M.I. Fersching, Christoph Salat et al. · Tumor Biology · 2012 · 82 citations

Medicine, Oncology, Cancer Immunology +16

Prospective, Multicenter Study of 5-Fluorouracil Therapeutic Drug Monitoring in Metastatic Colorectal Cancer Treated in Routine Clinical Practice

Martin Wilhelm, Lothar Mueller, Michael Craig Miller et al. · Clinical Colorectal Cancer · 2016 · 68 citations

Medicine, Oncology, Pharmacology +15

Relevance of histone marks H3K9me3 and H4K20me3 in cancer.

Gloria Leszinski, Uğur Gezer, Barbara Siegele et al. · PubMed · 2012 · 67 citations

Medicine, Molecular Biology, Oncology +17